Literature DB >> 2740829

Daily measurements of salivary progesterone reveal a high rate of anovulation in healthy students.

T Vuorento1, A Lahti, O Hovatta, I Huhtaniemi.   

Abstract

Daily concentrations of salivary progesterone (P) were measured from 32 women during a complete menstrual cycle. Seventeen of the subjects were university students and 15 were patients of an infertility clinic (a severe male-factor was verified as the cause of infertility in all of them). Commercially available reagents for radio-immunoassay of serum P were modified for salivary measurements, to yield acceptable precision and sensitivity (40 pmol/l). Good correlation (r = 0.93) was found between salivary and serum P concentrations in samples collected simultaneously. The follicular phase levels of salivary P were below 100 pmol/l, and those at the luteal peak were 390 +/- 45 pmol/l (mean +/- SEM, n = 24). From the menstrual salivary P concentration curves we identified the first day of significant elevation above mean follicular levels (T2) and thereafter calculated the cumulative sum of daily P concentrations until 95% of the luteal phase secretion had accumulated (C95). The time needed to reach C95 (designated T95) and logC95 were plotted in coordinates and used as the basis of evaluation of normal menstrual P secretion. The observations were distributed in two groups, one with clearly identifiable T2 and a distinct luteal-phase P (ovulation had occurred) and one with no identifiable T2 and absent luteal-phase P peak (indicative of anovulation). Interestingly, 47% of the student population had an abnormally low menstrual P profile while all the other subjects displayed a clear luteal-phase peak of salivary P. These data provide more evidence for applicability of salivary P measurements for diagnosis of corpus luteam function and highlight the difficulty of selecting representative reference populations in studies on female reproductive endocrinology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740829     DOI: 10.3109/00365518909089113

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

Review 1.  Effects of the menstrual cycle on exercise performance.

Authors:  Xanne A K Janse de Jonge
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.

Authors:  Gabriel Bodek; Susanna Vierre; Adolfo Rivero-Müller; Ilpo Huhtaniemi; Adam J Ziecik; Nafis A Rahman
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

3.  Salivary concentration of progesterone and cortisol significantly differs across individuals after correcting for blood hormone values.

Authors:  Shoko Konishi; Eleanor Brindle; Amanda Guyton; Kathleen A O'Connor
Journal:  Am J Phys Anthropol       Date:  2012-07-24       Impact factor: 2.868

4.  Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.

Authors:  J Kero; M Poutanen; F P Zhang; N Rahman; A M McNicol; J H Nilson; R A Keri; I T Huhtaniemi
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Progesterone and bone: actions promoting bone health in women.

Authors:  Vanadin Seifert-Klauss; Jerilynn C Prior
Journal:  J Osteoporos       Date:  2010-10-31

6.  Susceptibility to nausea and motion sickness as a function of the menstrual cycle.

Authors:  Robert L Matchock; Max E Levine; Peter J Gianaros; Robert M Stern
Journal:  Womens Health Issues       Date:  2008-05-15

7.  Steroid concentrations in antepartum and postpartum saliva: normative values in women and correlations with serum.

Authors:  Elizabeth Hampson; Shauna-Dae Phillips; Claudio N Soares; Meir Steiner
Journal:  Biol Sex Differ       Date:  2013-04-10       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.